
In the era of zzso therapies, tumor zzso has rarely been observed in phase I trials and zzso controlled trials have usually been required to demonstrate modest improvements over prevailing standards of zzso In the era of effective targeted therapies, drugs such as zzso and zzso have demonstrated convincing efficacy in early clinical testing, raising the question of whether zzso phase III trials are necessary and feasible before drug zzso Since 1992, the zzso has approved a number of drugs without data from zzso clinical trials as part of the accelerated approval zzso While this initiative has largely been successful in bringing effective drugs to the market more quickly, there is much to be learned from case studies of drugs, such as zzso which subsequently failed to gain full zzso In this Review, we use a number of historical examples to make the case that it may be reasonable to consider zzso zzso phase III trials for certain drugs before drug zzso We explore the consequences (both good and zzso of zzso zzso phase III trials and propose criteria that might be used to select drugs for consideration of such an zzso 

